Skip Ribbon Commands Skip to main content
Faculty
Michael Bouvet, MD

Michael Bouvet, MD, FACS

Professor of Surgery
Director of Endocrine Surgery
Co-Director of Gastrointestinal Cancer Unit, UC San Diego Moores Cancer Center

Endocrine Surgery; Surgical Oncology

 

Contact Information

(858) 822-6191
mbouvet@ucsd.edu








View clinical profile


Dr. Michael Bouvet specializes in surgical oncology and endocrine surgery. He pertabs surgeries for tumors of the pancreas, thyroid, parathyroid, adrenal, esophagus, and stomach, as well as for other conditions. He is also a specialist in endocrine surgery, including surgery for thyroid nodules and thyroid cancer, minimally invasive parathyroidectomy for primary hyperparathyroidism, and laparoscopic adrenal surgery. He is a member of the American Association of Endocrine Surgeons, the Society of Surgical Oncologists, the American Thyroid Association, and the American College of Surgeons. Dr. Bouvet is certified by the American Board of Surgery and has been selected as one of America’s Top Surgeons by the Consumers’ Research Council of America and one of San Diego's Top Doctors.

Dr. Bouvet has extensive training and experience in cancer surgery. He completed advanced fellowship training in surgical oncology at the renowned M. D. Anderson Cancer Center at the University of Texas. Here at UC San Diego, Dr. Bouvet is a key surgeon and researcher at the Moores UC San Diego Cancer Center, where he serves as Co-Director of the Specialized Gastrointestinal Cancer Care Unit, Director of Endocrine Surgery, and Director of Surgical Services.

Dr. Bouvet specializes in endocrine and pancreatic surgery. He routinely does surgery for thyroid nodules and thyroid cancer as well as minimally invasive surgery for hyperparathyroidism. He has performed many whipple procedures for pancreatic cancer.

In his research at UC San Diego, Dr. Bouvet conducts major investigations on the growth and spread of pancreatic cancer and the treatment of pancreatic cancer and other tumors. He is an investigator on several major National Cancer Institute-funded studies on the treatment, understanding, and monitoring of pancreatic cancer. In his recent medical publications, he reported the causes and factors that influence its growth as well as new techniques for imaging pancreatic cancer. Make a donation for pancreatic cancer research.

Research Overview

My research interests include the development of multi-color fluorescent orthotopic mouse models of pancreatic cancer to study the tumor microenvironment. In addition, our lab has developed tumor specific fluorescent probes that can be used to improve laparoscopic staging and complete surgical resection of GI malignancies. We also have several projects related to surgical outcomes in patients with thyroid cancer.

 

  • Angiogenesis
  • Cancer
  • Cell Biology
  • Endocrinology
  • Minimally Invasive Techniques
  • Outcomes

Current Project Titles

  • Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery
  • Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors
  • Tumor-stroma interactions in pancreatic cancer
  • Clinical outcomes in patients with thyroid cancer

Resources

Conditions and Treatments

  • Tran Cao HS, Johnston LE, Chang DC, Bouvet M. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. Surgery. 2012 152(2):145-51. Abstract
  • Johnston LE, Tran Cao HS, Chang DC, Bouvet M. Sociodemographic predictors of survival in differentiated thyroid cancer: results from the SEER database. ISRN Endocrinol. 2012;2012:384707. Epub 2012 Aug 16. Abstract
  • Baldassarre RL, Chang DC, Brumund KT, Bouvet M. Predictors of Hypocalcemia after Thyroidectomy: Results from the Nationwide Inpatient Sample. ISRN Surg. 2012;2012:838614. Epub 2012 Jul 15. Abstract | Full Text
  • Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: a review of the literature from the last decade. Thyroid. 2012 Mar;22(3):258-68. Epub 2012 Feb 7. Abstract | Full Text
  • Tran Cao HS, Kaushal S, Snyder CS, Ongkeko WM, Hoffman RM, Bouvet M. Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer. Anticancer Res. 2010 Nov;30(11):4415-22. Abstract
  • Chae A, Perricone A, Brumund KT, Bouvet M. Outpatient video-assisted thoracoscopic surgery (VATS) for ectopic mediastinal parathyroid adenoma: A case report and review of the literature. Journal of Laparoendoscopic & Advanced Surgical Techniques 18(3):383-90, 2008. Abstract
  • Lee JK, Obrzut SL, Yi ES, Deftos LJ, Bouvet M. Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism. Endocrine Practice 13(4):380-3, 2007. Abstract | Full Text
  • Newman EM, Bouvet M, Borgehi S, Herold DA, Deftos LJ. Causes of hypercalcemia in a population of military veterans in the United States. Endocrine Practice 12(5):535-41, 2006. Abstract | Full Text
  • Zhou W, Katz MH, Deftos LJ, Snyder CS, Baird S, Bouvet M. Metachronous double parathyroid adenomas involving two different cell types: chief and oxyphil cell: A case report. Endocrine Practice 9(6):522-525, 2003. Abstract | Full Text
  • Fleming J, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB. Standardized diagnostic and operative strategy for the treatment of medullary thyroid carcinoma. Annals of Surgery 230(5):697-707, 1999. Abstract | Full Text
  • Bouvet M, Feldman JI, Gill GN, Dillmann WH, Nahum AM, Russack V, Robbins KT. Surgical management of the thyroid nodule: patient selection based on the results of fine-needle aspiration cytology. Laryngoscope 102(12):1353-1356, 1992. Abstract | Full Text

Print